Search research articles
Contact Us
Filters
Showing results (181-190 of 222) with videos related to
Page
of 23
Sort By:
Journal of the American Academy of Dermatology
|
May 18, 2025
Skin clearance, duration of treatment-free interval, and safety of tapinarof cream 1% once daily: Results from ADORING 3, a 48-week phase 3 open-label extension trial in adults and children down to 2 years of age with atopic dermatitis
Robert Bissonnette, Linda Stein Gold, Leon Kircik, et al.
The Journal of Investigative Dermatology
|
August 7, 2022
Comparison of the Inflammatory Circuits in Psoriasis Vulgaris, Non‒Pustular Palmoplantar Psoriasis, and Palmoplantar Pustular Psoriasis
Claire Q Wang, Sokol Haxhinasto, Sandra Garcet, et al.
Journal of Cutaneous Medicine and Surgery
|
November 16, 2018
Approach to the Assessment and Management of Adult Patients With Atopic Dermatitis: A Consensus Document
Melinda J Gooderham, Chih-Ho Hong, Lorne Albrecht, et al.
Journal of Cutaneous Medicine and Surgery
|
November 16, 2018
Approach to the Assessment and Management of Adult Patients With Atopic Dermatitis: A Consensus Document. Section V: Consensus Statements on the Assessment and Management of Adult Patients With Moderate-to-Severe Atopic Dermatitis
Chih-Ho Hong, Melinda J Gooderham, Lorne Albrecht, et al.
The Journal of Allergy and Clinical Immunology
|
July 30, 2019
Oral Janus kinase/SYK inhibition (ASN002) suppresses inflammation and improves epidermal barrier markers in patients with atopic dermatitis
Ana B Pavel, Teresa Song, Hyun-Je Kim, et al.
Journal of Cutaneous Medicine and Surgery
|
March 20, 2024
Current Practices of Allergy Testing in Adults With Atopic Dermatitis in Canada: A National Survey
Erika Y Lee, Irina Turchin, An-Wen Chan, et al.
The New England Journal of Medicine
|
November 5, 2025
Oral Icotrokinra for Plaque Psoriasis in Adults and Adolescents
Robert Bissonnette, Jennifer Soung, Adelaide A Hebert, et al.
American Journal of Clinical Dermatology
|
June 20, 2020
Dupilumab Provides Favorable Safety and Sustained Efficacy for up to 3 Years in an Open-Label Study of Adults with Moderate-to-Severe Atopic Dermatitis
Lisa A Beck, Diamant Thaçi, Mette Deleuran, et al.
The Journal of Allergy and Clinical Immunology. in Practice
|
March 23, 2023
Dupilumab Inhibits Vascular Leakage of Blood Proteins Into Atopic Dermatitis Skin
Donald Y M Leung, Robert Bissonnette, Simion Kreimer, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV
|
May 23, 2026
Durability of response to icotrokinra for high-impact site psoriasis: 1-year ICONIC-TOTAL findings
Richard B Warren, Melinda Gooderham, Edward Lain, et al.
Page
of 23
Search research articles
Search
Showing results (181-190 of 222) with videos related to
Sort By:
Page
of 23
Journal of the American Academy of Dermatology
|
May 18, 2025
Skin clearance, duration of treatment-free interval, and safety of tapinarof cream 1% once daily: Results from ADORING 3, a 48-week phase 3 open-label extension trial in adults and children down to 2 years of age with atopic dermatitis
Robert Bissonnette, Linda Stein Gold, Leon Kircik, et al.
The Journal of Investigative Dermatology
|
August 7, 2022
Comparison of the Inflammatory Circuits in Psoriasis Vulgaris, Non‒Pustular Palmoplantar Psoriasis, and Palmoplantar Pustular Psoriasis
Claire Q Wang, Sokol Haxhinasto, Sandra Garcet, et al.
Journal of Cutaneous Medicine and Surgery
|
November 16, 2018
Approach to the Assessment and Management of Adult Patients With Atopic Dermatitis: A Consensus Document
Melinda J Gooderham, Chih-Ho Hong, Lorne Albrecht, et al.
Journal of Cutaneous Medicine and Surgery
|
November 16, 2018
Approach to the Assessment and Management of Adult Patients With Atopic Dermatitis: A Consensus Document. Section V: Consensus Statements on the Assessment and Management of Adult Patients With Moderate-to-Severe Atopic Dermatitis
Chih-Ho Hong, Melinda J Gooderham, Lorne Albrecht, et al.
The Journal of Allergy and Clinical Immunology
|
July 30, 2019
Oral Janus kinase/SYK inhibition (ASN002) suppresses inflammation and improves epidermal barrier markers in patients with atopic dermatitis
Ana B Pavel, Teresa Song, Hyun-Je Kim, et al.
Journal of Cutaneous Medicine and Surgery
|
March 20, 2024
Current Practices of Allergy Testing in Adults With Atopic Dermatitis in Canada: A National Survey
Erika Y Lee, Irina Turchin, An-Wen Chan, et al.
The New England Journal of Medicine
|
November 5, 2025
Oral Icotrokinra for Plaque Psoriasis in Adults and Adolescents
Robert Bissonnette, Jennifer Soung, Adelaide A Hebert, et al.
American Journal of Clinical Dermatology
|
June 20, 2020
Dupilumab Provides Favorable Safety and Sustained Efficacy for up to 3 Years in an Open-Label Study of Adults with Moderate-to-Severe Atopic Dermatitis
Lisa A Beck, Diamant Thaçi, Mette Deleuran, et al.
The Journal of Allergy and Clinical Immunology. in Practice
|
March 23, 2023
Dupilumab Inhibits Vascular Leakage of Blood Proteins Into Atopic Dermatitis Skin
Donald Y M Leung, Robert Bissonnette, Simion Kreimer, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV
|
May 23, 2026
Durability of response to icotrokinra for high-impact site psoriasis: 1-year ICONIC-TOTAL findings
Richard B Warren, Melinda Gooderham, Edward Lain, et al.
Page
of 23